A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor.
Saved in:
| Title: | A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor. |
|---|---|
| Authors: | Tsai, Max1, Chrones, Lambros1, Xie, Jinhui1, Gevorkyan, Hakop2, Macek, Thomas1 tom.macek@takeda.com |
| Source: | Psychopharmacology. Oct2016, Vol. 233 Issue 21/22, p3787-3795. |
| Database: | SPORTDiscus with Full Text |
Be the first to leave a comment!
